Laxmi Pandit-Silwal
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Assessing clinical decision support system tools in precision oncology: piloting ring testing.
Journal: ESMO real world data and digital oncology
Published: July 28, 2026
Elevated KRAS protein level is associated with better survival in pancreatic cancer.
Journal: BMC cancer
Published: April 27, 2025
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.
Journal: Molecular oncology
Published: July 11, 2023
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: February 10, 2022
Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.
Journal: Cancer research communications
Published: October 23, 2021
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 07, 2021
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
Journal: International journal of cancer
Published: November 01, 2019
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Journal: Genome medicine
Published: August 14, 2018
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: January 05, 2018
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.
Journal: Oncotarget
Published: February 23, 2017
Last Updated: 09/26/2026